Considering the inflammatory status related to metabolic syndrome and hepatic steatosis, we investigated the possible role of glycoproteins A and B in the detection of hepatic disease and their possible predictive capacities over a 10-year follow-up. The gene discussed is ART4; the disease is fatty liver disease.